Multivariate analysis of prognostic factors in patients with glioblastoma

作者: Johannes Lutterbach , Willi Sauerbrei , Roland Guttenberger

DOI: 10.1007/S00066-003-1004-5

关键词:

摘要: To identify prognostic factors for overall survival in patients with newly diagnosed glioblastoma undergoing radiation therapy. Patients and Methods: From January 1980 to June 2000, we treated 432 consecutive at out institution. 17 were excluded from the analysis various reasons. Mean age of 415 who included study was 59 years (19–81 years), Karnofsky performance status (KPS) ≥ 70 280 patients. 343 underwent resection, 72 had a biopsy. Various fractionation schemes used (conventional fractionation, n = 112; hypofractionation, 94; accelerated hyperfractionation, 209). Survival probabilities estimated using method Kaplan Meier. Multivariate done Cox regression model. Results: By July 2001, 406 died. Medial 8.2 months. Of ten considered proportional hazards model stratified treatment (fractionation scheme type surgery), significant variables multivariate (50–64 vs 240 U/l). including three variables, both parameters an additional effect relative risk about 1.4 their corresponding subgroups. Conclusion: Besides established factors, anemia raised serum LDH levels may negatively influence outcome Our results data-dependent modeling have be confirmed by independent studies.

参考文章(35)
Matthias C. Schmidt, Sven Antweiler, Nina Urban, Wolf Mueller, A. Kuklik, Birgit Meyer-Puttlitz, Otmar D. Wiestler, David N. Louis, Rolf Fimmers, Andreas von Deimling, Impact of Genotype and Morphology on the Prognosis of Glioblastoma Journal of Neuropathology and Experimental Neurology. ,vol. 61, pp. 321- 328 ,(2002) , 10.1093/JNEN/61.4.321
J. Vaquero, M. Zurita, S. Coca, S. Oya, Imbalance between apostain expression and proliferative index can predict survival in primary glioblastoma. Acta Neurochirurgica. ,vol. 144, pp. 151- 155 ,(2002) , 10.1007/S007010200018
Tanya S. Surawicz, Faith Davis, Sally Freels, Edward R. Laws Jr., Herman R. Menck, Brain tumor survival: results from the National Cancer Data Base. Journal of Neuro-oncology. ,vol. 40, pp. 151- 160 ,(1998) , 10.1023/A:1006091608586
Marie-Annick Forget, Richard R. Desrosiers, Rolanda F. Del Maestro, Robert Moumdjian, Daniel Shedid, France Berthelet, Richard Béliveau, The expression of rho proteins decreases with human brain tumor progression: potential tumor markers. Clinical & Experimental Metastasis. ,vol. 19, pp. 9- 15 ,(2002) , 10.1023/A:1013884426692
Maarten C.C.M. Hulshof, Radboud W. Koot, Eric C. Schimmel, Fido Dekker, D. Andries Bosch, Dionisio González González, Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution. Strahlentherapie Und Onkologie. ,vol. 177, pp. 283- 290 ,(2001) , 10.1007/PL00002409
U Lassen, K Osterlind, M Hansen, P Dombernowsky, B Bergman, H H Hansen, Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients. Journal of Clinical Oncology. ,vol. 13, pp. 1215- 1220 ,(1995) , 10.1200/JCO.1995.13.5.1215
L. Kleinberg, S. A. Grossman, S. Piantadosi, J. Pearlman, H. Engelhard, G. Lesser, J. Ruffer, M. Gerber, Phase I Trial to Determine the Safety, Pharmacodynamics, and Pharmacokinetics of RSR13, a Novel Radioenhancer, in Newly Diagnosed Glioblastoma Multiforme Journal of Clinical Oncology. ,vol. 17, pp. 2593- 2603 ,(1999) , 10.1200/JCO.1999.17.8.2593